Atlas Copco AB Series B (0XXV)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 172.10 |
|---|---|
| 52-week range | 135.03 – 185.85 |
| Return, 1 month / 3 months | −0.2% / +0.5% |
| Return, 1 year / 3 years | +19.6% / +40.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -18.7% |
| Average daily value traded | 164.64M SEK |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atlas Copco is an industrial group based in Sweden that supplies compressed air and vacuum equipment, power tools and assembly systems. Its compressors, vacuum pumps and air treatment products serve manufacturers, construction firms and process industries, while its industrial tools and assembly solutions are used in production lines and maintenance work. The company also provides related services and rental equipment to customers across many countries, supporting machinery and equipment used in factories, workshops and construction sites.
Atlas Copco AB Series B trades under the code 0XXV on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atlas Copco AB Series B (0XXV) trades on the London Exchange in UK. It last closed at SEK 172.10 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 655 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.6% and over the last three months it rose 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -7.2% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.5% | ||
| 6-month return | 3.3% | ||
| 12-month return, skipping the last month | 19.8% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.7% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 164.64M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.1% |
|---|---|
| 1 month | −0.2% |
| 3 months | +0.5% |
| 6 months | +3.2% |
| 1 year | +19.6% |
| 3 years | +40.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 178.23 / 166.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Oct 2025 | SEK 1.5000 |
| 30 Apr 2025 | SEK 1.5000 |
| 18 Oct 2024 | SEK 1.4000 |
| 25 Apr 2024 | SEK 1.4000 |
| 19 Oct 2023 | SEK 1.1500 |
| 28 Apr 2023 | SEK 1.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.